Herena Eixarch

1.3k total citations
31 papers, 781 citations indexed

About

Herena Eixarch is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Herena Eixarch has authored 31 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Herena Eixarch's work include Immunotherapy and Immune Responses (8 papers), Multiple Sclerosis Research Studies (7 papers) and Immune Cell Function and Interaction (6 papers). Herena Eixarch is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Multiple Sclerosis Research Studies (7 papers) and Immune Cell Function and Interaction (6 papers). Herena Eixarch collaborates with scholars based in Spain, United States and Canada. Herena Eixarch's co-authors include Carmen Espejo, Xavier Montalbán, Jordi Barquinero, Laura Calvo‐Barreiro, Carme Costa, Mireia Castillo, Luisa María Villar, María José Mansilla, Roland Martinꝉ and Elena Martínez‐Sáez and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and American Journal Of Pathology.

In The Last Decade

Herena Eixarch

29 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herena Eixarch Spain 18 393 221 132 122 107 31 781
Kazuki Ishibashi Japan 14 400 1.0× 317 1.4× 81 0.6× 73 0.6× 57 0.5× 29 1.3k
Sydney M. Escobar United States 10 251 0.6× 274 1.2× 69 0.5× 66 0.5× 94 0.9× 12 764
Kathleen Myers United States 12 327 0.8× 245 1.1× 62 0.5× 54 0.4× 87 0.8× 12 795
Sabine Wolter Germany 15 479 1.2× 129 0.6× 35 0.3× 68 0.6× 73 0.7× 29 753
Mireia Castillo Spain 10 204 0.5× 123 0.6× 153 1.2× 50 0.4× 49 0.5× 16 492
Nora Müller Germany 18 239 0.6× 414 1.9× 66 0.5× 32 0.3× 53 0.5× 26 913
Baozhong Xin United States 18 599 1.5× 187 0.8× 68 0.5× 50 0.4× 181 1.7× 35 1.0k
Martha Robles‐Flores Mexico 19 663 1.7× 125 0.6× 56 0.4× 39 0.3× 55 0.5× 52 1.0k
Carson E. Moseley United States 9 181 0.5× 448 2.0× 79 0.6× 47 0.4× 31 0.3× 17 777
Eleonora Piras Italy 10 277 0.7× 105 0.5× 183 1.4× 40 0.3× 29 0.3× 13 597

Countries citing papers authored by Herena Eixarch

Since Specialization
Citations

This map shows the geographic impact of Herena Eixarch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herena Eixarch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herena Eixarch more than expected).

Fields of papers citing papers by Herena Eixarch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herena Eixarch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herena Eixarch. The network helps show where Herena Eixarch may publish in the future.

Co-authorship network of co-authors of Herena Eixarch

This figure shows the co-authorship network connecting the top 25 collaborators of Herena Eixarch. A scholar is included among the top collaborators of Herena Eixarch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herena Eixarch. Herena Eixarch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eixarch, Herena, Arnau Hervera, Mireia Castillo, et al.. (2025). Disease Aggravation With Age in an Experimental Model of Multiple Sclerosis: Role of Immunosenescence. Aging Cell. 24(5). e14491–e14491. 2 indexed citations
2.
3.
Eixarch, Herena, et al.. (2025). Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal Transduction and Targeted Therapy. 10(1). 324–324. 1 indexed citations
4.
Fissolo, Nicolás, Laura Calvo‐Barreiro, Herena Eixarch, et al.. (2023). Molecular signature associated with cladribine treatment in patients with multiple sclerosis. Frontiers in Immunology. 14. 1233546–1233546. 3 indexed citations
5.
Calvo‐Barreiro, Laura, et al.. (2022). Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis. Neurotherapeutics. 19(5). 1617–1633. 6 indexed citations
6.
Eixarch, Herena, et al.. (2021). Immunosenescence in multiple sclerosis: the identification of new therapeutic targets. Autoimmunity Reviews. 20(9). 102893–102893. 60 indexed citations
7.
Eixarch, Herena, Laura Calvo‐Barreiro, Carme Costa, et al.. (2020). Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis. Neurotherapeutics. 17(4). 1988–2003. 6 indexed citations
8.
Planas, Raquel, Radleigh G. Santos, Carolina Cruciani, et al.. (2018). GDP- l -fucose synthase is a CD4 + T cell–specific autoantigen in DRB3*02:02 patients with multiple sclerosis. Science Translational Medicine. 10(462). 64 indexed citations
9.
Costa, Carme, Herena Eixarch, Elena Martínez‐Sáez, et al.. (2018). Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions. American Journal Of Pathology. 189(3). 665–676. 21 indexed citations
10.
Calvo‐Barreiro, Laura, Herena Eixarch, Xavier Montalbán, & Carmen Espejo. (2017). Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis. Autoimmunity Reviews. 17(2). 165–174. 71 indexed citations
11.
Eixarch, Herena, Carme Costa, Keiji Hirota, et al.. (2017). Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor. Neurotherapeutics. 14(4). 1095–1106. 11 indexed citations
12.
Eixarch, Herena, Laura Calvo‐Barreiro, Xavier Montalbán, & Carmen Espejo. (2017). Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammation. Brain Behavior and Immunity. 68. 1–10. 25 indexed citations
13.
Eixarch, Herena, Carme Costa, Vanessa Gil, et al.. (2016). Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis. Molecular Neurobiology. 54(6). 4820–4831. 30 indexed citations
14.
Costa, Carme, Herena Eixarch, Mireia Castillo, et al.. (2015). Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design. Clinical Immunology. 163. 22–33. 27 indexed citations
15.
Mansilla, María José, Carme Costa, Herena Eixarch, et al.. (2014). Hsp70 Regulates Immune Response in Experimental Autoimmune Encephalomyelitis. PLoS ONE. 9(8). e105737–e105737. 38 indexed citations
16.
Eixarch, Herena, María José Mansilla, Carme Costa, et al.. (2013). Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis. Neuroscience Letters. 541. 161–166. 19 indexed citations
17.
Eixarch, Herena, et al.. (2013). Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis. Trends in Molecular Medicine. 19(3). 157–164. 38 indexed citations
18.
Torres‐Torronteras, Javier, Herena Eixarch, Lluís Palenzuela, et al.. (2011). Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Therapy. 18(8). 795–806. 47 indexed citations
19.
Eixarch, Herena, Carmen Espejo, María José Mansilla, et al.. (2009). Tolerance Induction in Experimental Autoimmune Encephalomyelitis Using Non-myeloablative Hematopoietic Gene Therapy With Autoantigen. Molecular Therapy. 17(5). 897–905. 22 indexed citations
20.
Puig, Teresa, Elisabet Kádár, Ana Limón, et al.. (2002). Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene. Gene Therapy. 9(21). 1472–1479. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuki Ishibashi Breakdown of academic impact, for papers by Sydney M. Escobar Breakdown of academic impact, for papers by Kathleen Myers Breakdown of academic impact, for papers by Sabine Wolter Breakdown of academic impact, for papers by Mireia Castillo Breakdown of academic impact, for papers by Nora Müller Breakdown of academic impact, for papers by Baozhong Xin Breakdown of academic impact, for papers by Martha Robles‐Flores Breakdown of academic impact, for papers by Carson E. Moseley Breakdown of academic impact, for papers by Eleonora Piras
Rankless by CCL
2026